HRA Pharma continues to monitor the developing situation with COVID-19 and have created a dedicated crisis
management unit to ensure that our support for the communities we serve remains uninterrupted. As of 17th
March, we are all working from home and are fully operational.
We would like to reassure our customers, our patients and our healthcare professionals of our commitment to providing access to our products and medicines and to our support of those in our patient communities. Please do not hesitate in calling or emailing us when needed.
Our thoughts go to patients and to all healthcare providers who are at the front line of the COVID-19 pandemic.
Building on our strengths, focused on our future.
Our ambition for the years to come is to become one of the fastest growing global Consumer Healthcare companies, empowering people throughout the world to improve their lives by developing accessible, value added self-care solutions.
We invite you to take a look at our product portfolio in women’s health.
Please note that brand names may differ depending on where you live or practice. HRA Pharma’s products in your country: Regulatory status of the products may vary depending on the country. Please contact us to get more information.
In our HRA Pharma Wound Care portfolio we offer Compeed.
A global brand that offers a wide variety of high-quality solutions for preventing and treating blisters, bunions, callus, corns, cracked heels and cold sores. Visit the Compeed Website for more information.
HRA Pharma Rare Diseases, an affiliate “Devoted to the rare”, offering treatments for Cushing’s Syndrome and Adrenocortical Carcinoma.
At HRA Pharma Rare Diseases, we are a team of passionate people, dedicated to rare and ultra-rare diseases, serving the neglected rare disease communities; patients who are not being diagnosed promptly and have difficulty accessing life-saving medicines, as well as rare diseases’ specialists who are treating them.
Our mission is to continue fighting so no patient is left behind!